0000000000392673

AUTHOR

V. Candiloro

showing 3 related works from this author

Erythromycin reverses the daunomycin resistance of MEL-DRTL cells

1990

PharmacologyChemistrymedicineErythromycinPharmacologymedicine.drugPharmacological Research
researchProduct

Cathepsin D, B and L circulating levels as prognostic markers of malignant progression

1996

Growing evidence indicates that lysosomal Cathepsins D (CD), B (CB) and L (CL) may promote carcinogenesis and tumor progression. Therefore, we evaluated their potential value as biochemical parameters of malignant progression in patients with benign diseases which may undergo malignant transformation, such as liver cirrhosis (LC) and chronic pancreatitis (CHP) as well as in hepatocellular carcinoma (HCC) and pancreatic cancer (DPC). CD, CB and CL serum levels were determined by immunoenzymatic assays in LC, CHP, HCC or DPC patients and correlated with a number of biochemical and clinical parameters of these diseases. CD serum levels were increased in LC, CHP and HCC, but not in the DPC grou…

AdultAged 80 and overMaleTumor progression.Carcinoma HepatocellularCirrhosiVHepatocellular carcinomaCathepsin LLiver NeoplasmsPancreatic cancerMiddle AgedPrognosisCathepsin DCathepsinsLCathepsin BPancreatic NeoplasmsCysteine EndopeptidasesChronic HepatiticEndopeptidasesBiomarkers TumorHumansFemaleAged
researchProduct

Isolated myocardiocytes and DNA synthesis: a possible experimental model to predict the in vivo cardiotoxicity

1989

PharmacologyCardiotoxicityHeart DiseasesDNA synthesisBiological modelingbusiness.industryExperimental modelMyocardiumDNAPharmacologyModels BiologicalRatsMiceDoxorubicinIn vivoToxicityAnimalsMedicineMitoxantronebusinessPharmacological Research
researchProduct